Pediococcus acidilactici

The BioCollective® Awarded Groundbreaking Probiotic Patent

Retrieved on: 
Thursday, March 7, 2024
Ecology, The, Diabetes, Parkinson's disease, Probiotic, Human microbiome, Carbohydrate metabolism, Pediococcus acidilactici, Blood, Patent, Use, Disease, Health, Type 2 diabetes, Triglyceride, Leuconostoc mesenteroides, DSM-IV codes, Patient, Insulin, United States patent law, Clinical trial, Research, Dietary supplement

DENVER, March 7, 2024 /PRNewswire-PRWeb/ -- The BioCollective, a pioneer in microbiome research and consumer probiotics, today announced it has been granted a patent for a system of probiotics to manage and potentially treat a range of significant health issues.

Key Points: 
  • The issued composition-of-matter patent covers probiotic formulations to prevent or limit disease conditions, restore lost physiological function, and reduce gastrointestinal infection by modulating gastrointestinal mannitol.
  • The patent covers a range of clinical conditions, including diabetes, metabolic diseases, gastrointestinal infections, and neurological diseases.
  • The US Patent and Trademark Office issued US Patent No.
  • The company's BiotiQuest® Sugar Shift® probiotic and additional products in its development pipeline are covered under the patent.

Agri-Neo's Neo-Pure Pasteurization Technology Receives TERP Validation

Retrieved on: 
Friday, December 2, 2022
Enterococcus faecium, Escherichia coli, Process, Pediococcus acidilactici, Pediococcus, Seed, Food safety, FDA, Pasteurization, NPP, ABC, TERP, Steam, Food, Fumigation, PPO, Onion, Vaccine, Pharmaceutical industry, Listeria, Salmonella

TORONTO, Dec. 2, 2022 /PRNewswire-PRWeb/ -- Agri-Neo is pleased to announce that the Neo-Pure continuous food safety system, and organic pasteurization process at their Toronto Headquarters, have been validated by an ABC-approved Process Authority with agreement by ABC TERP that the Neo-Pure Food Safety System equipment and conditions used in the study demonstrate an ability to meet ABC's criteria of a minimum 4-log destruction of Salmonella bacteria on whole brownskin almonds. Agri-Neo's food safety science studies and third-party test results showed Neo-Pure meets ABC's criteria of a minimum 4-log reduction of pathogens on California almonds.

Key Points: 
  • "We are excited to provide a new pasteurization option to the California almond industry," said Rob Wong, President of Agri-Neo.
  • "Neo-Pure is a proven pasteurization technology for California almonds," said Dr. Fadi Dagher, Biochemistry Director of Agri-Neo.
  • "Neo-Pure is the only TERP-validated pasteurization technology validated using two surrogate bacteria: Pediococcus acidilactici and Enterococcus faecium.
  • The use of surrogate bacteria in food safety is considered a critical component in food safety technology validations.

Visbiome® Vet probiotic to be the subject of two new clinical trials in domestic dogs

Retrieved on: 
Wednesday, September 12, 2018
Bacteria, Probiotics, Digestive system, Bacteriology, Medicine, Lactobacillaceae, Microbiology, Bifidobacteriales, Lactobacillus paracasei, Pediococcus acidilactici

Visbiome Vet is an 8-strain probiotic compound with an extremely high concentration of beneficial bacteria (112.5 billion bacteria per dose).

Key Points: 
  • Visbiome Vet is an 8-strain probiotic compound with an extremely high concentration of beneficial bacteria (112.5 billion bacteria per dose).
  • The formulation in Visbiome Vet is one of the most extensively studied probiotic products for pets, as it has been the subject of four controlled clinical trials.
  • The formulation in Visbiome Vet contains an eight-strain proprietary probiotic blend that has recently been studied in several canine GI disorders.
  • Visbiome Vet is the identical formulation to Visbiome, a human medical food that has been the subject of over 60 clinical trials.

Microbial LLC Launches Profauna 100, a High-Count, Multi-Strain Probiotic for Dogs to Support Digestive Health

Retrieved on: 
Wednesday, June 6, 2018
Bacteriology, Digestive system, Probiotic, Gut flora, Biology, Biotic, Pediococcus acidilactici, Prebiotic

GAITHERSBURG, Md., June 6, 2018 /PRNewswire/ -- The Microbial LLC, a company primarily focused on developing and commercializing high quality pet probiotics that benefit the animal microbiome, launched Profauna 100, a new high-count, multi-strain probiotic specifically developed to support a dog's digestive health.

Key Points: 
  • GAITHERSBURG, Md., June 6, 2018 /PRNewswire/ -- The Microbial LLC, a company primarily focused on developing and commercializing high quality pet probiotics that benefit the animal microbiome, launched Profauna 100, a new high-count, multi-strain probiotic specifically developed to support a dog's digestive health.
  • Digestive health issues such as diarrhea, vomiting, and loss of appetite are the second most common health issues for dogs and can happen when a dog's gut bacteria or microbiome is out of balance.
  • We developed Profauna 100 specifically for dogs as an alternative for consumers using human probiotics or canine probiotics that haven't been effective.
  • Utilizing the latest research, the company has developed its first product specifically designed for dogs to support the stand-alone or combination use of probiotic therapy.